THE DISPOSITION OF BIPHENYLACETIC ACID FOLLOWING TOPICAL APPLICATION

被引：33

作者：

DAWSON, M

MCGEE, CM

VINE, JH

NASH, P

WATSON, TR

BROOKS, PM

机构：

[1] ROYAL N SHORE HOSP,ST LEONARDS,NSW 2065,AUSTRALIA

[2] SYDNEY HOSP,DEPT PHARM,SYDNEY,NSW 2000,AUSTRALIA

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 33卷 / 06期

关键词：

D O I：

10.1007/BF00542502

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：639 / 642

页数：4

共 9 条

[1] PHARMACOKINETICS OF FENBUFEN IN MAN [J].

CUISINAUD, G ;

LEGHEAND, J ;

LLORCA, G ;

BELKAHIA, C ;

LEJEUNE, E ;

SASSARD, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (01) :59-61

[2] QUANTITATION OF BIPHENYLACETIC ACID IN PLASMA AND SYNOVIAL-FLUID BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY MASS-SPECTROMETRY [J].

DAWSON, M ;

MCGEE, CM ;

BROOKS, PM ;

VINE, JH ;

LACEY, E ;

WATSON, TR .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 420 (01) :129-134

[3]

Furst D E, 1985, Agents Actions Suppl, V17, P65

[4]

KEWAR SS, 1983, J AM MED ASS, V250, P84

[5] BASIC AND CLINICAL-STUDIES OF PRODRUGS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [J].

MIZUSHIMA, Y .

PHARMACOLOGY, 1982, 25 :39-45

[6]

ROBINSON JR, 1979, SUSTAINED CONTROLLED

[7]

ROPES MW, 1959, ANN RHEUM DIS, V18, P49

[8]

SUGAWARA Y, 1985, J MED PHARM, V13

[9] INHIBITION OF PROSTAGLANDIN SYNTHESIS AS A MECHANISM OF ACTION FOR ASPIRIN-LIKE DRUGS [J].

VANE, JR .

NATURE-NEW BIOLOGY, 1971, 231 (25) :232-&

← 1 →